These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30768)

  • 41. A comparison of high- and low-dose lorazepam with amylobarbitone in patients with anxiety states.
    Schapira K; McClelland HA; Newell DJ
    Am J Psychiatry; 1977 Jan; 134(1):25-8. PubMed ID: 12665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the safety and therapeutic effects of lorazepam on long-term use.
    Siassi I; Thomas M; Vanov SK
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):163-71. PubMed ID: 240649
    [No Abstract]   [Full Text] [Related]  

  • 43. Alprazolam in the treatment of neurotic anxiety.
    Kerry RJ; McDermott CM
    Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clorazepate: double blind crossover comparison of a single nightly dose with diazepam thrice daily in anxiety.
    Magnus RV; Dean BC; Curry SH
    Dis Nerv Syst; 1977 Oct; 38(10):819-21. PubMed ID: 20284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
    Fischer-Cornelssen KA
    Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092
    [No Abstract]   [Full Text] [Related]  

  • 46. A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy.
    Park SH; Bang SM; Nam E; Cho EK; Shin DB; Lee JH; Ahn JY
    Pain Med; 2008 Mar; 9(2):249-52. PubMed ID: 18298709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of suriclone, lorazepam and placebo in anxiety disorder.
    de Jonghe F; Swinkels J; Tuynman-Qua H; Jonkers F
    Pharmacopsychiatry; 1989 Nov; 22(6):266-71. PubMed ID: 2575766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind cross-over clinical comparison of two 2'-chloro benzodiazepines: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (chlordesmethyldiazepam) versus 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in neurotic anxiety.
    Andreoli V; Maffei F; Montanaro N; Morandini G
    Arzneimittelforschung; 1977 Feb; 27(2):436-9. PubMed ID: 16622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes.
    Honderick T; Williams D; Seaberg D; Wears R
    Am J Emerg Med; 2003 Jan; 21(1):39-42. PubMed ID: 12563578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO₂-induced anxiety.
    Diaper A; Papadopoulos A; Rich AS; Dawson GR; Dourish CT; Nutt DJ; Bailey JE
    Hum Psychopharmacol; 2012 Nov; 27(6):540-8. PubMed ID: 23027657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study.
    Ananth V; Beszterczy A; Geagea C
    Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825
    [No Abstract]   [Full Text] [Related]  

  • 54. Lorazepam in anxiety with GI disorders.
    Rider JA
    Psychosomatics; 1977 Aug; 18(3):55-8. PubMed ID: 19808
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of anxiety with bromazepam in clinical practice (author's transl)].
    Bornstein S; Benoudich H; Kaufman E; Konqui M; Pigeon P
    Nouv Presse Med; 1982 May; 11(22):1731-4. PubMed ID: 6124945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A method for evaluating anxiolytic sedatives.
    Wang RI; Wiesen RL; Stockdale S; Hieb E
    J Clin Pharmacol; 1977; 17(5-6):269-75. PubMed ID: 16039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of lorazepam oral fast dissolving drug formulation (FDDF) in anesthesia premedication in adults: a double-blind placebo controlled comparison.
    Van de Velde A; Camu F
    Acta Anaesthesiol Belg; 1988; 39(2):95-100. PubMed ID: 3400411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effective short-term treatment of generalized anxiety disorder with trifluoperazine.
    Mendels J; Krajewski TF; Huffer V; Taylor RJ; Secunda S; Schless A; Sebastian JA; Semchyshyn G; Durr MJ; Melmed AS
    J Clin Psychiatry; 1986 Apr; 47(4):170-4. PubMed ID: 3514583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lorazepam and diazepam in the treatment of benign paroxysmal vertigo.
    McClure JA; Willett JM
    J Otolaryngol; 1980 Dec; 9(6):472-7. PubMed ID: 6110782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lormetazepam - a benzodiazepine derivative without hangover effect? A double-blind study with chronic insomniacs in a general practice setting.
    Heidrich H; Ott H; Beach RC
    Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):11-7. PubMed ID: 6110634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.